The Supplementary Material (Supplemental Digital Content, http://links.lww.com/MD/H126) includes SLC22A8 expression levels in other cancers, the relationship between SLC22A8 DNA methylation levels and clinical features, and the results of enrichment analysis. The gene discussed is SLC22A8; the disease is cancer.